In April 2025 the company announced it was struggling with more than US $1.4 billion debt and were filing for bankruptcy (Ferguson)
Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL
BPC-157 (Body Protection Compound-157) is a synthetic peptide that has garnered attention for its potential regenerative and healing properties
A research article about the doseresponse effects of survodutide, a dual agonist of the subcutaneous glucagon receptor and glucagon-like peptide- 1 receptor, on bodyweight loss and HbA1c levels
That means it is under evaluation